Home Cart 0 Sign in  
X

[ CAS No. 1696-20-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1696-20-4
Chemical Structure| 1696-20-4
Chemical Structure| 1696-20-4
Structure of 1696-20-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1696-20-4 ]

Related Doc. of [ 1696-20-4 ]

Alternatived Products of [ 1696-20-4 ]

Product Details of [ 1696-20-4 ]

CAS No. :1696-20-4 MDL No. :MFCD00006171
Formula : C6H11NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KYWXRBNOYGGPIZ-UHFFFAOYSA-N
M.W : 129.16 Pubchem ID :15543
Synonyms :

Calculated chemistry of [ 1696-20-4 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.83
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.94
TPSA : 29.54 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.59
Log Po/w (XLOGP3) : -1.22
Log Po/w (WLOGP) : -0.52
Log Po/w (MLOGP) : -0.41
Log Po/w (SILICOS-IT) : 0.67
Consensus Log Po/w : 0.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.19
Solubility : 202.0 mg/ml ; 1.56 mol/l
Class : Highly soluble
Log S (Ali) : 1.09
Solubility : 1610.0 mg/ml ; 12.4 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.36
Solubility : 56.0 mg/ml ; 0.434 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.34

Safety of [ 1696-20-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1696-20-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1696-20-4 ]
  • Downstream synthetic route of [ 1696-20-4 ]

[ 1696-20-4 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 1696-20-4 ]
  • [ 73671-59-7 ]
  • [ 932-16-1 ]
  • [ 932-62-7 ]
  • [ 156210-71-8 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2013, vol. 50, # 4, p. 795 - 808
  • 2
  • [ 15159-40-7 ]
  • [ 917-54-4 ]
  • [ 1696-20-4 ]
  • [ 38952-62-4 ]
  • [ 6342-79-6 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 21, p. 3703 - 3706
  • 3
  • [ 22029-65-8 ]
  • [ 108-24-7 ]
  • [ 1696-20-4 ]
  • [ 2873-97-4 ]
YieldReaction ConditionsOperation in experiment
76%
Stage #1: at 20 - 80℃; for 2 h; Inert atmosphere
Stage #2: Reflux
Under argon protection, 11.2 g of acetic anhydride and 25.6 g were addedN - (2-methyl-4-oxapentan-2-yl) -3-morpholinopropionamideThe raw material is mixed with 250 ml of toluene, and the temperature is slowly increased from room temperature to 60 to 80 DEG C and stirred for 2 hours. After stirringMix and then add 0.2 g inhibitor BHT and 0.1 g cuprous chloride and 10.8 g triethylamine, and gradually warmed to reflux reactionNight, the reaction system was concentrated under reduced pressure to give the crude product which was directly separated by silica gel column chromatography with hexane-ethyl acetate14.1 grams of purified pure acrylamide (85percent yield) and 9.8 grams of pure N-acetylmorpholine (76percent yield).
Reference: [1] Patent: CN107417644, 2017, A, . Location in patent: Paragraph 0023
  • 4
  • [ 616-47-7 ]
  • [ 1696-20-4 ]
  • [ 85692-37-1 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 44, p. 11546 - 11549[2] Angew. Chem., 2013, vol. 125, # 44, p. 11760 - 11763
[3] Chemical Communications, 2016, vol. 52, # 55, p. 8604 - 8607
[4] Journal of the American Chemical Society, 2005, vol. 127, # 42, p. 14675 - 14680
[5] Advanced Synthesis and Catalysis, 2018, vol. 360, # 6, p. 1094 - 1098
  • 5
  • [ 1696-20-4 ]
  • [ 100367-77-9 ]
  • [ 160060-21-9 ]
Reference: [1] Organic Letters, 2009, vol. 11, # 16, p. 3690 - 3693
  • 6
  • [ 1696-20-4 ]
  • [ 154447-36-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 2, p. 569 - 585
  • 7
  • [ 1696-20-4 ]
  • [ 154447-35-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 2, p. 569 - 585
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1696-20-4 ]

Amides

Chemical Structure| 51068-78-1

[ 51068-78-1 ]

2-Hydroxy-1-morpholinoethanone

Similarity: 0.93

Chemical Structure| 1440-61-5

[ 1440-61-5 ]

4-(2-Chloroacetyl)morpholine

Similarity: 0.82

Chemical Structure| 109-11-5

[ 109-11-5 ]

Morpholin-3-one

Similarity: 0.81

Chemical Structure| 40299-87-4

[ 40299-87-4 ]

2-Bromo-1-morpholinoethanone

Similarity: 0.80

Chemical Structure| 82846-38-6

[ 82846-38-6 ]

2,2'-Oxybis(N,N-dibutylacetamide)

Similarity: 0.75

Related Parent Nucleus of
[ 1696-20-4 ]

Aliphatic Heterocycles

Chemical Structure| 51068-78-1

[ 51068-78-1 ]

2-Hydroxy-1-morpholinoethanone

Similarity: 0.93

Chemical Structure| 4394-85-8

[ 4394-85-8 ]

Morpholine-4-carbaldehyde

Similarity: 0.89

Chemical Structure| 1440-61-5

[ 1440-61-5 ]

4-(2-Chloroacetyl)morpholine

Similarity: 0.82

Chemical Structure| 109-11-5

[ 109-11-5 ]

Morpholin-3-one

Similarity: 0.81

Chemical Structure| 38952-61-3

[ 38952-61-3 ]

N,N-Dimethylmorpholine-4-carboxamide

Similarity: 0.71

Morpholines

Chemical Structure| 51068-78-1

[ 51068-78-1 ]

2-Hydroxy-1-morpholinoethanone

Similarity: 0.93

Chemical Structure| 4394-85-8

[ 4394-85-8 ]

Morpholine-4-carbaldehyde

Similarity: 0.89

Chemical Structure| 1440-61-5

[ 1440-61-5 ]

4-(2-Chloroacetyl)morpholine

Similarity: 0.82

Chemical Structure| 109-11-5

[ 109-11-5 ]

Morpholin-3-one

Similarity: 0.81

Chemical Structure| 40299-87-4

[ 40299-87-4 ]

2-Bromo-1-morpholinoethanone

Similarity: 0.80